NCT02604173View on ClinicalTrials.gov

Altitude Sickness Prevention and Efficacy of Comparative Treatments

PHASE3CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Acute Mountain Sickness
Interventions
DRUG

Budesonide

Inhaled Budesonide vs. PO Acetazolamide vs. Placebo for prevention of Acute Mountain Sickness

DRUG

Acetazolamide

Inhaled Budesonide vs. PO Acetazolamide vs. Placebo for prevention of Acute Mountain Sickness

DRUG

Placebo

Placebo pill and sham inhaler

Trial Locations (1)

93514

Owens Valley Lodge - White Mountain Research Station, Bishop

All Listed Sponsors
lead

Stanford University

OTHER

NCT02604173 - Altitude Sickness Prevention and Efficacy of Comparative Treatments | Biotech Hunter | Biotech Hunter